116 related articles for article (PubMed ID: 28377056)
1. Synthesis and SAR studies of 3,6-disubstituted indazole derivatives as potent hepcidin production inhibitors.
Fukuda T; Ueda K; Ishiyama T; Goto R; Muramatsu S; Hashimoto M; Watanabe K; Tanaka N
Bioorg Med Chem Lett; 2017 May; 27(10):2148-2152. PubMed ID: 28377056
[TBL] [Abstract][Full Text] [Related]
2. Discovery of DS28120313 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4,6-disubstituted indazole derivatives.
Fukuda T; Goto R; Kiho T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Watanabe K; Tanaka N
Bioorg Med Chem Lett; 2017 Dec; 27(23):5252-5257. PubMed ID: 29079471
[TBL] [Abstract][Full Text] [Related]
3. Discovery of DS79182026: A potent orally active hepcidin production inhibitor.
Fukuda T; Goto R; Kiho T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Watanabe K; Tanaka N
Bioorg Med Chem Lett; 2017 Aug; 27(16):3716-3722. PubMed ID: 28705644
[TBL] [Abstract][Full Text] [Related]
4. Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives.
Fukuda T; Ishiyama T; Katagiri T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Baba D; Watanabe K; Tanaka N
Bioorg Med Chem Lett; 2018 Nov; 28(20):3333-3337. PubMed ID: 30217414
[TBL] [Abstract][Full Text] [Related]
5. Low anticoagulant heparin-iron complex targeting inhibition of hepcidin ameliorates anemia of chronic disease in rodents.
Li L; Wang X; Zhang H; Chen Q; Cui H
Eur J Pharmacol; 2021 Apr; 897():173958. PubMed ID: 33610598
[TBL] [Abstract][Full Text] [Related]
6. Target identification of hepcidin production inhibitors by a combination of chemical proteomics and radioactive compound binding assay.
Sasaki M; Ueda K; Fukuda T; Tanaka N; Shimizu H; Kubota K
Biochem Biophys Res Commun; 2018 Sep; 503(4):2878-2884. PubMed ID: 30139518
[TBL] [Abstract][Full Text] [Related]
7. Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia.
Poli M; Asperti M; Ruzzenenti P; Naggi A; Arosio P
Molecules; 2017 Apr; 22(4):. PubMed ID: 28397746
[TBL] [Abstract][Full Text] [Related]
8. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia.
Lasocki S; Millot S; Andrieu V; Lettéron P; Pilard N; Muzeau F; Thibaudeau O; Montravers P; Beaumont C
Crit Care Med; 2008 Aug; 36(8):2388-94. PubMed ID: 18664788
[TBL] [Abstract][Full Text] [Related]
9. Pentosan polysulfate to control hepcidin expression in vitro and in vivo.
Asperti M; Denardo A; Gryzik M; Castagna A; Girelli D; Naggi A; Arosio P; Poli M
Biochem Pharmacol; 2020 May; 175():113867. PubMed ID: 32088260
[TBL] [Abstract][Full Text] [Related]
10. Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo.
Poli M; Asperti M; Ruzzenenti P; Mandelli L; Campostrini N; Martini G; Di Somma M; Maccarinelli F; Girelli D; Naggi A; Arosio P
Biochem Pharmacol; 2014 Dec; 92(3):467-75. PubMed ID: 25241290
[TBL] [Abstract][Full Text] [Related]
11. Analysis of IL-22 contribution to hepcidin induction and hypoferremia during the response to LPS in vivo.
Wallace DF; Subramaniam VN
Int Immunol; 2015 Jun; 27(6):281-7. PubMed ID: 25568302
[TBL] [Abstract][Full Text] [Related]
12. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K
BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103
[TBL] [Abstract][Full Text] [Related]
13. [Peripheral blood monocyte hepcidin in patients with multiple myeloma is associated with anemia of chronic disease].
Han X; Zhou DB; Duan MH; Wang X; Zhang JP; Zhao YQ; Shen T; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):403-9. PubMed ID: 23628042
[TBL] [Abstract][Full Text] [Related]
14. IL-22 regulates iron availability in vivo through the induction of hepcidin.
Smith CL; Arvedson TL; Cooke KS; Dickmann LJ; Forte C; Li H; Merriam KL; Perry VK; Tran L; Rottman JB; Maxwell JR
J Immunol; 2013 Aug; 191(4):1845-55. PubMed ID: 23836059
[TBL] [Abstract][Full Text] [Related]
15. Fragment-Based Discovery of Pyrimido[1,2-b]indazole PDE10A Inhibitors.
Chino A; Seo R; Amano Y; Namatame I; Hamaguchi W; Honbou K; Mihara T; Yamazaki M; Tomishima M; Masuda N
Chem Pharm Bull (Tokyo); 2018; 66(3):286-294. PubMed ID: 29491261
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis.
Shu T; Jing C; Lv Z; Xie Y; Xu J; Wu J
Eur J Haematol; 2015 Jan; 94(1):67-73. PubMed ID: 24954786
[TBL] [Abstract][Full Text] [Related]
17. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.
Nemeth E; Rivera S; Gabayan V; Keller C; Taudorf S; Pedersen BK; Ganz T
J Clin Invest; 2004 May; 113(9):1271-6. PubMed ID: 15124018
[TBL] [Abstract][Full Text] [Related]
18. The role of hepcidin in chronic mild stress-induced depression.
Farajdokht F; Soleimani M; Mehrpouya S; Barati M; Nahavandi A
Neurosci Lett; 2015 Feb; 588():120-4. PubMed ID: 25576700
[TBL] [Abstract][Full Text] [Related]
19. Using histamine (H1) antagonists, in particular atypical antipsychotics, to treat anemia of chronic disease via interleukin-6 suppression.
Altschuler EL; Kast RE
Med Hypotheses; 2005; 65(1):65-7. PubMed ID: 15893120
[TBL] [Abstract][Full Text] [Related]
20. Correlation between hepcidin level and renal anemia.
Yang LN; Zhang P; Tang F; Wang G; Li FE
Genet Mol Res; 2014 Sep; 13(3):7407-10. PubMed ID: 25222239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
